---
figid: PMC7709261__40364_2020_252_Fig1_HTML
figtitle: Outline of TGFB signaling pathway regulating HCC initiation and progression
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7709261
filename: 40364_2020_252_Fig1_HTML.jpg
figlink: pmc/articles/PMC7709261/figure/Fig1/
number: F1
caption: Outline of TGF-β signaling pathway regulating HCC initiation and progression.
  TGF-β affect downstream molecules through canonical (SMADs) and noncanonical (AKT,
  KRAS, EGFR, STAT3 and PDGF) pathway to regulate several HCC-related processes. Many
  downstream molecules of TGF-β signaling pathway were reported to involve in the
  processes including liver fibrogenesis (p38, STAT3),tumor growth (Ki-67, MYC, Artemin
  and NF-kB) stemness (CD44, CD133, EpCAM and β-catenin), EMT (N-cadherin, AXL and
  Snail), apoptosis (EGFR, p-AKT) and immune inhibition (CD86, CD96, PD-1 and HLA-DR)
papertitle: Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular
  carcinoma.
reftext: Mengzhen Han, et al. Biomark Res. 2020;8:70.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8120068
figid_alias: PMC7709261__F1
figtype: Figure
redirect_from: /figures/PMC7709261__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7709261__40364_2020_252_Fig1_HTML.html
  '@type': Dataset
  description: Outline of TGF-β signaling pathway regulating HCC initiation and progression.
    TGF-β affect downstream molecules through canonical (SMADs) and noncanonical (AKT,
    KRAS, EGFR, STAT3 and PDGF) pathway to regulate several HCC-related processes.
    Many downstream molecules of TGF-β signaling pathway were reported to involve
    in the processes including liver fibrogenesis (p38, STAT3),tumor growth (Ki-67,
    MYC, Artemin and NF-kB) stemness (CD44, CD133, EpCAM and β-catenin), EMT (N-cadherin,
    AXL and Snail), apoptosis (EGFR, p-AKT) and immune inhibition (CD86, CD96, PD-1
    and HLA-DR)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - NRAS
  - ITK
  - SLC22A3
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - STAT3
  - AXL
  - SNAI2
  - SNAI1
  - TWIST1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - MMP9
  - CDH2
  - TGFBR2
  - TGFB1
  - TGFB2
  - TGFB3
  - MYC
  - HCC
  - HYCC1
  - NFKB1
  - THBS1
  - TGFBR1
  - PCNA
  - CD44
  - PROM1
  - CTNNB1
  - CD86
  - CD96
  - HLA-DRA
  - HLA-DRB1
  - HLA-DRB3
  - HLA-DRB4
  - HLA-DRB5
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
---
